Delivery Order SPE2DB25D9348-SPE2DB25FNMVK
- Not listed
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 52 milligram Mirena systems valued at $4,686.93. This firm fixed-price delivery order, awarded July 30, 2025, with an ultimate completion date of August 20, 2025, represents performance at the contractor's Park Ridge facility. The award carries no set-aside designation and falls under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a continuation of DMS Pharmaceutical Group's substantial role as a pharmaceutical supplier to the Department of Defense. The award...
- The Defense Logistics Agency awarded a $2,182 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 52 mg Mirena systems. This firm fixed-price delivery order, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a routine procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at approximately $500 million through November...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency awarded a $2,603.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg contraceptive systems on July 29, 2025, with an ultimate completion date of August 19, 2025. This delivery order was issued without a set-aside designation and is being performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, is the prime contractor on this award. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective July 25, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,645.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Mirena 52 mg systems. The contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price structure with no set-aside designation applied. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a delivery order valued at $5,207.70 for Mirena 52 mg systems, effective July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a discrete procurement under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued at approximately $500 million through November 2026. The award carries no set-aside designation, allowing the woman-owned small...
- The Defense Logistics Agency (DLA) awarded a $3,124.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 28, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The award carries no set-aside designation, and performance will be executed in Park...
- SPE2DB25D9348Indefinite Delivery Contract
- SPE2DB25D9348-SPE2DB25FNMVKDelivery Order
The Defense Logistics Agency awarded a $6,249.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Mirena 52 mg systems. The award was issued on July 28, 2025, with an ultimate completion date of August 18, 2025. No set-aside designation was used for this procurement. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through the SPE2DB program, which enables the agency to issue firm fixed-price orders for pharmaceutical supplies supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts to deliver branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's portfolio includes an extensive range of pharmaceutical products spanning contraceptive devices, oncology treatments, injections, and specialty medications. This particular delivery order for Mirena 52 mg systems—a long-acting reversible contraceptive implant—exemplifies the company's role in providing essential medical supplies to support military healthcare operations across the defense enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 7/28/25 |